Summary of Changes – 1 August 2025

Page last updated: 1 August 2025

Previous versions of the Summary of Changes are available in PDF in the Publications Archive.

Additions
Deletions
Alterations
Supply Only
Advance Notices
Palliative Care
Highly Specialised Drugs Program (Private Hospital)
Highly Specialised Drugs Program (Public Hospital)
Highly Specialised Drugs Program (Community Access)
Repatriation Pharmaceutical Benefits
Efficient Funding of Chemotherapy (Private Hospital)
Efficient Funding of Chemotherapy (Public Hospital)
Related Pharmaceutical Benefits for Public Hospital use

General Pharmaceutical Benefits

Additions

Addition – Item

14931W	DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 3 x 28 (Slinda)
14941J	DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28 (Bella, Rosie, YANA)
14954C	DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28 (Bella, Rosie, YANA)
14876Y	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14886L	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14887M	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14896B	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14877B	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14879D	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14890Q	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14891R	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14892T	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14898D	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14899E	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14908P	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14909Q	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14916C	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14933Y	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14944M	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma)
14878C	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14893W	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14897C	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14907N	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14917D	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14918E	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14926N	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14934B	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14935C	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)
14943L	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma)

Addition – Brand

2698B	ZYRON, NB – ABIRATERONE, abiraterone acetate 250 mg tablet, 120
11206T	ZYRON, NB – ABIRATERONE, abiraterone acetate 500 mg tablet, 60
9320M	Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 75 mg capsule, 60
13523R	Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60
2753X	Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60
9321N	Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60
13489Y	Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 150 mg capsule, 60
2769R	Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 150 mg capsule, 60
5457F	Jubbonti, SZ – DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe
10061M	Wyost, SZ – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial
5110Y	Wyost, SZ – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial
14711G	Isabelle, GQ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
14711G	Rosalee, SZ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
14711G	Yelena, XT – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
14725B	Isabelle, GQ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
14725B	Rosalee, SZ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
14725B	Yelena, XT – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
14349F	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28
14519E	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28
8700X	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28
9432K	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28
14415Q	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28
14416R	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28
8701Y	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28
9433L	ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28
11621P	Isotretinoin Dr.Reddy's, RZ – ISOTRETINOIN, isotretinoin 20 mg capsule, 30
2592K	Isotretinoin Dr.Reddy's, RZ – ISOTRETINOIN, isotretinoin 20 mg capsule, 60
13463N	Relaban, NB – RIVAROXABAN, rivaroxaban 15 mg tablet, 28
2691P	Relaban, NB – RIVAROXABAN, rivaroxaban 15 mg tablet, 28
13462M	Relaban, NB – RIVAROXABAN, rivaroxaban 20 mg tablet, 28
2268J	Relaban, NB – RIVAROXABAN, rivaroxaban 20 mg tablet, 28
10551H	Rizatriptan-Au, DZ – RIZATRIPTAN, rizatriptan 10 mg orally disintegrating tablet, 2
13261Y	Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13273N	Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13789R	Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13805N	Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
5469W	Varenicline Lupin, GQ – VARENICLINE, varenicline 1 mg tablet, 56
9129L	Varenicline Lupin, GQ – VARENICLINE, varenicline 1 mg tablet, 56
9128K	Varenicline Lupin, GQ – VARENICLINE, varenicline 500 microgram tablet [11] (&) varenicline 1 mg tablet [42], 53

Addition – Equivalence Indicator

5457F	Prolia, AN – DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe
10061M	Xgeva, AN – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial
5110Y	Xgeva, AN – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial
14711G	Yasmin, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
14725B	Yasmin, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
14709E	Yaz, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28
14710F	Yaz, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28
13261Y	Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13273N	Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13789R	Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13805N	Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe

Addition – Note

5457F	DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe (Jubbonti, Prolia)
10061M	DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial (Wyost, Xgeva)
5110Y	DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial (Wyost, Xgeva)
14709E	DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28 (Yaz)
14710F	DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28 (Yaz)

Deletions

Deletion – Item

11329G	AFATINIB, afatinib 50 mg tablet, 28 (Giotrif)
11342Y	AFATINIB, afatinib 50 mg tablet, 28 (Giotrif)
14194C	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (RA-Morph (NZ))
14204N	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (RA-Morph (NZ))
8589C	QUINAPRIL + HYDROCHLOROTHIAZIDE, quinapril 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 (Accuretic 10/12.5mg)
8590D	QUINAPRIL + HYDROCHLOROTHIAZIDE, quinapril 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 (Accuretic 20/12.5mg)
14636H	TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA))
10622C	YELLOW JACKET VENOM, yellow jacket venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial], 1 pack (Hymenoptera Yellow Jacket Venom)

Deletion – Brand

1052J	Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 800 mg tablet, 35
8878G	Durogesic 12, JC – FENTANYL, fentanyl 12 microgram/hour patch, 5
8891Y	Durogesic 25, JC – FENTANYL, fentanyl 25 microgram/hour patch, 5
8892B	Durogesic 50, JC – FENTANYL, fentanyl 50 microgram/hour patch, 5
8893C	Durogesic 75, JC – FENTANYL, fentanyl 75 microgram/hour patch, 5
8894D	Durogesic 100, JC – FENTANYL, fentanyl 100 microgram/hour patch, 5
8729K	Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule
8730L	Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule
14526M	Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28
8627C	Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28
10005N	Olmekar HCT 20/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30
13481M	Olmekar HCT 20/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30
13512E	Olmekar HCT 40/5/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30
13513F	Olmekar HCT 40/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30
2864R	Olmekar HCT 40/5/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30
2880N	Olmekar HCT 40/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30
13482N	Olmekar HCT 40/10/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30
14002Y	Olmekar HCT 40/10/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30
2836G	Olmekar HCT 40/10/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30
2953K	Olmekar HCT 40/10/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30
14367E	Noumed Paroxetine, VO – PAROXETINE, paroxetine 20 mg tablet, 30
2242B	Noumed Paroxetine, VO – PAROXETINE, paroxetine 20 mg tablet, 30

Deletion – Equivalence Indicator

8729K	Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule
8730L	Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule

Deletion – Note

14275H	ADALIMUMAB, adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (Humira)
14747E	ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (Amgevita)
14750H	ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada)
14221L	ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
14591Y	ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
14251C	ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Abrilada, Amgevita, Hadlima, Hyrimoz)
14261N	ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
14297L	CABOZANTINIB, cabozantinib 20 mg tablet, 30 (Cabometyx)
14254F	CABOZANTINIB, cabozantinib 40 mg tablet, 30 (Cabometyx)
14237H	CABOZANTINIB, cabozantinib 60 mg tablet, 30 (Cabometyx)
11276L	TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (CIPLA TENOFOVIR + EMTRICITABINE 300/200, TENOFOVIR/EMTRICITABINE 300/200 APX, TENOFOVIR/EMTRICITABINE 300/200 ARX)
11296M	TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 (Tenofovir Disoproxil Emtricitabine Viatris 300/200)
12542D	TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 (Tenofovir/Emtricitabine Sandoz 301/200)
12662K	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
12664M	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
13789R	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)

Deletion – Restriction

14275H	ADALIMUMAB, adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (Humira)
14747E	ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (Amgevita)
14750H	ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada)
14221L	ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
14591Y	ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
14251C	ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Abrilada, Amgevita, Hadlima, Hyrimoz)
14261N	ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
14297L	CABOZANTINIB, cabozantinib 20 mg tablet, 30 (Cabometyx)
14254F	CABOZANTINIB, cabozantinib 40 mg tablet, 30 (Cabometyx)
14237H	CABOZANTINIB, cabozantinib 60 mg tablet, 30 (Cabometyx)

Alterations

Alteration – Item Description

From
14638K	DAPAGLIFLOZIN + SITAGLIPTIN, dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100)
To
14638K	DAPAGLIFLOZIN + SITAGLIPTIN, Dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100)
From
14645T	DAPAGLIFLOZIN + SITAGLIPTIN, dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100)
To
14645T	DAPAGLIFLOZIN + SITAGLIPTIN, Dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100)
From
14792M	EPCORITAMAB, epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
To
14792M	EPCORITAMAB, Epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
From
14809K	EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
To
14809K	EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
From
14819Y	EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
To
14819Y	EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
From
14617H	ICOSAPENT ETHYL, icosapent ethyl 998 mg capsule, 120 (Vazkepa)
To
14617H	ICOSAPENT ETHYL, Icosapent ethyl 998 mg capsule, 120 (Vazkepa)
From
14743Y	MOMELOTINIB, momelotinib 100 mg tablet, 30 (Omjjara)
To
14743Y	MOMELOTINIB, Momelotinib 100 mg tablet, 30 (Omjjara)
From
14769H	MOMELOTINIB, momelotinib 100 mg tablet, 30 (Omjjara)
To
14769H	MOMELOTINIB, Momelotinib 100 mg tablet, 30 (Omjjara)
From
14744B	MOMELOTINIB, momelotinib 150 mg tablet, 30 (Omjjara)
To
14744B	MOMELOTINIB, Momelotinib 150 mg tablet, 30 (Omjjara)
From
14762Y	MOMELOTINIB, momelotinib 150 mg tablet, 30 (Omjjara)
To
14762Y	MOMELOTINIB, Momelotinib 150 mg tablet, 30 (Omjjara)
From
14763B	MOMELOTINIB, momelotinib 200 mg tablet, 30 (Omjjara)
To
14763B	MOMELOTINIB, Momelotinib 200 mg tablet, 30 (Omjjara)
From
14770J	MOMELOTINIB, momelotinib 200 mg tablet, 30 (Omjjara)
To
14770J	MOMELOTINIB, Momelotinib 200 mg tablet, 30 (Omjjara)

Alteration – Brand Name

From
14408H	Chemists’ Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets
To
14408H	Chemists' Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets
From
8612G	Chemists’ Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets
To
8612G	Chemists' Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets

Alteration – Note

14077X	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL (Morphini HCl Streuli)
14083F	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL (Morphini HCl Streuli)
2124T	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (Ordine 10)
5239R	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (Ordine 10)
10767Q	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
10774C	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
11178H	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
12669T	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
9304Q	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
9305R	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
13261Y	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)
13273N	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)
13805N	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)

Alteration – Restriction

14116Y	ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio)
14105J	ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio)
14134X	ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio)
10767Q	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
10774C	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
11178H	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
12662K	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
12664M	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
12669T	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
9304Q	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
9305R	USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
13261Y	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)
13273N	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)
13789R	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)
13805N	USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma)

Alteration – Number of Repeats

		From	To
14573B	MIGALASTAT, migalastat 123 mg capsule, 14 (Galafold)	5	6

Supply Only

Supply Only – Period Commencing

9438R	AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN, amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 24 g sachets (GA gel)
14425F	BETAXOLOL, betaxolol 0.5% eye drops, 5 mL (Betoptic)
2825Q	BETAXOLOL, betaxolol 0.5% eye drops, 5 mL (Betoptic)
5544T	BETAXOLOL, betaxolol 0.5% eye drops, 5 mL (Betoptic)
8527T	TENECTEPLASE, tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack (Metalyse)

Supply Only – Period Ending

11287C	GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS, glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent powder for oral liquid, 60 x 16 g sachets (PKU Build 10)
2676W	PROTEIN HYDROLYSATE FORMULA WITH MEDIUM CHAIN TRIGLYCERIDES, protein hydrolysate formula with medium chain triglycerides powder for oral liquid, 400 g (Alfaré)

Advance Notices

1 September 2025

Deletion – Brand

14726C	Acarbose 50 mg tablets (Morningside, UK), DZ – ACARBOSE, acarbose 50 mg tablet, 90
14735M	Acarbose 50 mg tablets (Morningside, UK), DZ – ACARBOSE, acarbose 50 mg tablet, 90
1555W	Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 200 mg tablet, 50
13575L	Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 300 mg tablet, 60
2604C	Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 300 mg tablet, 60
3417W	HCU Anamix junior LQ, SB – AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS AND TRACE ELEMENTS WITHOUT METHIONINE AND SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID, amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without methionine and supplemented with docosahexaenoic acid oral liquid, 36 x 125 mL bottles
9330C	TYR Anamix junior LQ, SB – AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS AND TRACE ELEMENTS WITHOUT PHENYLALANINE AND TYROSINE, AND SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID, amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexaenoic acid oral liquid, 36 x 125 mL bottles
9499Y	MSUD Anamix Junior LQ, SB – AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT VALINE, LEUCINE AND ISOLEUCINE WITH FAT, CARBOHYDRATE AND TRACE ELEMENTS AND SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID, amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexaenoic acid oral liquid, 36 x 125 mL bottles
8596K	Amipride 400, RW – AMISULPRIDE, amisulpride 400 mg tablet, 60
13532F	Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 5 mg tablet, 30
13562T	Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 10 mg tablet, 30
2751T	Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 5 mg tablet, 30
2752W	Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 10 mg tablet, 30
11941L	Amoxycillin/Clavulanic Acid 500/125 APOTEX, TY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10
1891M	Amoxycillin/Clavulanic Acid 500/125 APOTEX, TY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10
5008N	Amoxycillin/Clavulanic Acid 500/125 APOTEX, TY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10
5296R	Riamet 20mg/120mg Dispersible, NV – ARTEMETHER + LUMEFANTRINE, artemether 20 mg + lumefantrine 120 mg dispersible tablet, 18
13391T	Blooms the Chemist Candesartan HCTZ 16/12.5, IB – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30
8504N	Blooms the Chemist Candesartan HCTZ 16/12.5, IB – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30
8439E	Blooms the Chemist Celecoxib, IB – CELECOXIB, celecoxib 100 mg capsule, 60
8439E	Celecoxib APOTEX, TY – CELECOXIB, celecoxib 100 mg capsule, 60
8440F	Blooms the Chemist Celecoxib, IB – CELECOXIB, celecoxib 200 mg capsule, 30
8440F	Celecoxib APOTEX, TY – CELECOXIB, celecoxib 200 mg capsule, 30
5265D	Denpax, AF – FENTANYL, fentanyl 12 microgram/hour patch, 5
5277R	Denpax, AF – FENTANYL, fentanyl 25 microgram/hour patch, 5
5278T	Denpax, AF – FENTANYL, fentanyl 50 microgram/hour patch, 5
5279W	Denpax, AF – FENTANYL, fentanyl 75 microgram/hour patch, 5
5280X	Denpax, AF – FENTANYL, fentanyl 100 microgram/hour patch, 5
5437E	Fenpatch 12, RW – FENTANYL, fentanyl 12 microgram/hour patch, 5
5438F	Fenpatch 25, RW – FENTANYL, fentanyl 25 microgram/hour patch, 5
5439G	Fenpatch 50, RW – FENTANYL, fentanyl 50 microgram/hour patch, 5
5440H	Fenpatch 75, RW – FENTANYL, fentanyl 75 microgram/hour patch, 5
5441J	Fenpatch 100, RW – FENTANYL, fentanyl 100 microgram/hour patch, 5
10915L	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
10918P	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
10920R	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
10924Y	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
10940T	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
10941W	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
10942X	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
11757T	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
11770L	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
11776T	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
11777W	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
11782D	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
11783E	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
11875B	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
12709X	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
12710Y	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
12722N	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
12759M	Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60
13564X	Blooms the Chemist Irbesartan, IB – IRBESARTAN, irbesartan 300 mg tablet, 30
8248D	Blooms the Chemist Irbesartan, IB – IRBESARTAN, irbesartan 300 mg tablet, 30
13446Q	Blooms the Chemist Irbesartan HCTZ 300/25, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30
13545X	Blooms the Chemist Irbesartan HCTZ 300/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30
13572H	Blooms the Chemist Irbesartan HCTZ 150/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30
2136K	Blooms the Chemist Irbesartan HCTZ 300/25, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30
8404H	Blooms the Chemist Irbesartan HCTZ 150/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30
8405J	Blooms the Chemist Irbesartan HCTZ 300/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30
14553Y	Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28
8628D	Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28
13747M	Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 100 mL
13749P	Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 500 mL
13753W	Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 100 mL
13760F	Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 500 mL
14077X	Morphini HCl Streuli, DZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL
14083F	Morphini HCl Streuli, DZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL
1653B	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 10 mg modified release tablet, 28
1654C	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 30 mg modified release tablet, 28
1655D	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 60 mg modified release tablet, 28
1656E	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 100 mg modified release tablet, 28
14000W	MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50
8650G	MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50
13449W	Olmesartan/Amlodipine 20/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30
5292M	Olmesartan/Amlodipine 20/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30
11682W	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
12281J	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
1326T	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
1327W	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
14464G	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
14465H	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
14559G	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
14706B	Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30
1594X	APO-Ondansetron, TX – ONDANSETRON, ondansetron 4 mg tablet, 10
1595Y	APO-Ondansetron, TX – ONDANSETRON, ondansetron 8 mg tablet, 10
8224W	APO-Ondansetron, TX – ONDANSETRON, ondansetron 4 mg tablet, 4
8225X	APO-Ondansetron, TX – ONDANSETRON, ondansetron 8 mg tablet, 4
14367E	APO-Paroxetine, TX – PAROXETINE, paroxetine 20 mg tablet, 30
2242B	APO-Paroxetine, TX – PAROXETINE, paroxetine 20 mg tablet, 30
13371R	Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
13372T	Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
13404L	Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3050M	Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3051N	Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
8704D	Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
13898L	APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 15 mg tablet, 28
8694N	APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 15 mg tablet, 28
14324X	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 375 microgram modified release tablet, 30
14325Y	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet, 30
14360T	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet, 30
14459B	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 750 microgram modified release tablet, 30
14460C	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3 mg modified release tablet, 30
14461D	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet, 30
14556D	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet, 30
3418X	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 375 microgram modified release tablet, 30
3419Y	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 750 microgram modified release tablet, 30
3420B	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet, 30
3421C	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3 mg modified release tablet, 30
3422D	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet, 30
5143Q	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet, 30
5145T	APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet, 30
2348N	Blooms The Chemist Pregabalin, IB – PREGABALIN, pregabalin 25 mg capsule, 56
2355Y	Blooms The Chemist Pregabalin, IB – PREGABALIN, pregabalin 150 mg capsule, 56
2363J	Blooms The Chemist Pregabalin, IB – PREGABALIN, pregabalin 300 mg capsule, 56
13406N	Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30
2606E	Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30
11993F	APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5
12001P	APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
1760P	APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
5260W	APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
5261X	APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5
8016X	APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5
5480K	Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 30
8064K	Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 42
8133C	Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 10
8134D	Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 30

1 October 2025

Deletion – Brand

13419G	NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 2.5 mg tablet, 28
13443M	NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 5 mg tablet, 28
13444N	NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 10 mg tablet, 28
8604W	NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 2.5 mg tablet, 28
8605X	NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 5 mg tablet, 28
8606Y	NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 10 mg tablet, 28
1475P	Fluconazole APOTEX, GX – FLUCONAZOLE, fluconazole 200 mg capsule, 28
14526M	Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28
14553Y	Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28
8627C	Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28
8628D	Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28
8185T	Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 5 mg tablet, 28
13964Y	Olmesartan/Amlodipine 40/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30
5293N	Olmesartan/Amlodipine 40/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30
5470X	Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 4
5472B	Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 10

1 November 2025

Deletion – Brand

8559L	Gabapentin APOTEX, TY – GABAPENTIN, gabapentin 600 mg tablet, 100
10916M	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
10917N	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
10921T	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
10925B	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
10933K	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
10935M	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
10939R	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
11756R	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
11763D	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
11764E	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
11771M	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
11772N	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
11779Y	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
11870R	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
12681K	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
12711B	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
12723P	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
12754G	Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30
14501F	Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 20 mg enteric tablet, 30
8399C	Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 20 mg enteric tablet, 30
13921Q	APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 30 mg tablet, 28
8695P	APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 30 mg tablet, 28

Palliative Care

Deletions

Deletion – Item

14187Q

MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (RA-Morph (NZ))

Deletion – Brand

12541C	Durogesic 12, JC – FENTANYL, fentanyl 12 microgram/hour patch, 5
12504D	Durogesic 25, JC – FENTANYL, fentanyl 25 microgram/hour patch, 5
12477Q	Durogesic 50, JC – FENTANYL, fentanyl 50 microgram/hour patch, 5
12474M	Durogesic 75, JC – FENTANYL, fentanyl 75 microgram/hour patch, 5
12509J	Durogesic 100, JC – FENTANYL, fentanyl 100 microgram/hour patch, 5

Alterations

Alteration – Brand Name

From
5389P	Chemists’ Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets
To
5389P	Chemists' Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets

Alteration – Note

12472K	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (Ordine 10)
14081D	MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL (Morphini HCl Streuli)

Advance Notices

1 September 2025

Deletion – Brand

12480W	Fenpatch 100, RW – FENTANYL, fentanyl 100 microgram/hour patch, 5
12491K	Denpax, AF – FENTANYL, fentanyl 12 microgram/hour patch, 5
12513N	Fenpatch 50, RW – FENTANYL, fentanyl 50 microgram/hour patch, 5
12516R	Denpax, AF – FENTANYL, fentanyl 25 microgram/hour patch, 5
12517T	Fenpatch 75, RW – FENTANYL, fentanyl 75 microgram/hour patch, 5
12521B	Fenpatch 25, RW – FENTANYL, fentanyl 25 microgram/hour patch, 5
12526G	Denpax, AF – FENTANYL, fentanyl 75 microgram/hour patch, 5
12530L	Fenpatch 12, RW – FENTANYL, fentanyl 12 microgram/hour patch, 5
12533P	Denpax, AF – FENTANYL, fentanyl 100 microgram/hour patch, 5
12546H	Denpax, AF – FENTANYL, fentanyl 50 microgram/hour patch, 5
12483B	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 100 mg modified release tablet, 28
12500X	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 30 mg modified release tablet, 28
12544F	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 60 mg modified release tablet, 28
12547J	MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 10 mg modified release tablet, 28
13743H	Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 100 mL
13748N	Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 500 mL
14081D	Morphini HCl Streuli, DZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL

Highly Specialised Drugs Program (Private Hospital)

Additions

Addition – Item

14900F	EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil)
14910R	EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil)
14888N	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14915B	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14882G	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo)
14904K	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14919F	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo)
14921H	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14939G	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14883H	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14903J	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14911T	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14923K	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14927P	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14928Q	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14938F	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14912W	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14930T	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14940H	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14951X	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14953B	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)

Note - Erratum
The listing of ivacaftor item codes 14902H and 14936D is no longer proceeding for 1 August 2025.

Addition – Brand

10110D	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
10956P	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11826K	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11840E	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11952C	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11958J	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
10122R	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
10968G	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11163M	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11175E	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11825J	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11864K	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11932B	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11953D	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11164N	Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13255P	Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13804M	Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial

Addition – Equivalence Indicator

10110D	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
10956P	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11826K	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11840E	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11952C	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11958J	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11164N	Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13255P	Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13804M	Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial

Addition – Note

10110D	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10956P	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11826K	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11840E	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10122R	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11825J	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11864K	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)

Addition – Caution

10956P	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11952C	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11958J	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10968G	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11932B	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11953D	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)

Deletions

Deletion – Brand

10122R	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
10968G	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11163M	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11175E	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11825J	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11864K	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11932B	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11953D	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe

Alterations

Alteration – Item Description

From
14828K	MACITENTAN + TADALAFIL, macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi)
To
14828K	MACITENTAN + TADALAFIL, Macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi)
From
14829L	VUTRISIRAN, vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra)
To
14829L	VUTRISIRAN, Vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra)

Alteration – Note

11163M	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11175E	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11953D	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11164N	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13255P	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13804M	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)

Alteration – Restriction

14147N	IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco)
14165M	IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco)
11097C	IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco)
14158E	IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco)
11109Q	IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco)
14157D	IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco)
10175M	IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco)
14169R	IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco)
10956P	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10968G	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11175E	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11953D	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11164N	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13255P	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13804M	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)

Alteration – Restriction Level

		From	To
11953D	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)	authority-required	streamlined

Advance Notices

1 September 2025

Deletion – Brand

6209T	MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50
6280M	Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 100

Highly Specialised Drugs Program (Public Hospital)

Additions

Addition – Item

14880E	EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil)
14894X	EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil)
14914Y	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14924L	FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev)
14905L	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14920G	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo)
14947Q	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo)
14949T	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14950W	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14884J	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14922J	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14929R	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14937E	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14945N	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14946P	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14948R	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14885K	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14895Y	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14906M	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14913X	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14952Y	OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)

Note - Erratum
The listing of ivacaftor item codes 14881F and 14901G is no longer proceeding for 1 August 2025.

Addition – Brand

10118M	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
10967F	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11835X	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11846L	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11946R	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11962N	Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
10109C	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
10973M	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11168T	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11176F	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11824H	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11828M	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11945Q	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11950Y	Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11182M	Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13272M	Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13781H	Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial

Addition – Equivalence Indicator

10118M	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
10967F	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11835X	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11846L	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11946R	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11962N	Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11182M	Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13272M	Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13781H	Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial

Addition – Note

10118M	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10967F	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11835X	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11846L	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10109C	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11824H	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11828M	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)

Addition – Caution

10967F	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11946R	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11962N	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10973M	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11945Q	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11950Y	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)

Deletions

Deletion – Brand

10109C	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
10973M	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11168T	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11176F	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11824H	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11828M	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11945Q	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe
11950Y	Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe

Alterations

Alteration – Item Description

From
14785E	MACITENTAN + TADALAFIL, macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi)
To
14785E	MACITENTAN + TADALAFIL, Macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi)
From
14810L	VUTRISIRAN, vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra)
To
14810L	VUTRISIRAN, Vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra)

Alteration – Note

11168T	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11176F	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11945Q	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11182M	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13272M	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13781H	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)

Alteration – Restriction

14155B	IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco)
14156C	IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco)
11105L	IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco)
14148P	IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco)
11098D	IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco)
14167P	IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco)
10170G	IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco)
14153X	IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco)
10967F	OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
10973M	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11176F	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11945Q	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11182M	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13272M	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)
13781H	USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma)

Alteration – Restriction Level

		From	To
11945Q	OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)	authority-required	streamlined

Advance Notices

1 September 2025

Deletion – Brand

9502D	MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50
9568N	Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 100

Highly Specialised Drugs Program (Community Access)

Deletions

Deletion – Item

14637J

TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA))

Deletion – Brand

10310P	Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30
11992E	Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30

Deletion – Note

10347N	TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (CIPLA TENOFOVIR + EMTRICITABINE 300/200, TENOFOVIR/EMTRICITABINE 300/200 APX, TENOFOVIR/EMTRICITABINE 300/200 ARX)
11149T	TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 (Tenofovir Disoproxil Emtricitabine Viatris 300/200)
12506F	TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 (Tenofovir/Emtricitabine Sandoz 301/200)

Advance Notices

1 October 2025

Deletion – Brand

10348P	Lamivudine Alphapharm, AF – LAMIVUDINE, lamivudine 150 mg tablet, 60
10310P	Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30
11992E	Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30

Repatriation Pharmaceutical Benefits

Additions

Addition – Brand

4115N	Azithromycin-WGR, WG – AZITHROMYCIN, azithromycin 500 mg tablet, 3
4592Q	GABAPENTIN-WGR, WG – GABAPENTIN, gabapentin 300 mg capsule, 100
4593R	GABAPENTIN-WGR, WG – GABAPENTIN, gabapentin 400 mg capsule, 100
4594T	APX-GABAPENTIN, TX – GABAPENTIN, gabapentin 600 mg tablet, 100
4350Y	MUPIROCIN-WGR, WG – MUPIROCIN, mupirocin 2% ointment, 15 g
10598T	APOHEALTH Osteo Relief Paracetamol 665 mg, TX – PARACETAMOL, paracetamol 665 mg modified release tablet, 96
14197F	RISEDRONATE-WGR, WG – RISEDRONATE, risedronate sodium 35 mg tablet, 4
4444X	RISEDRONATE-WGR, WG – RISEDRONATE, risedronate sodium 35 mg tablet, 4
4596X	TADALAFIL-WGR, WG – TADALAFIL, tadalafil 10 mg tablet, 4
4597Y	TADALAFIL-WGR, WG – TADALAFIL, tadalafil 20 mg tablet, 4
14200J	TAMSULOSIN-WGR SR, WG – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30
4070F	TAMSULOSIN-WGR SR, WG – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30
4011D	TERBINAFINE-WGR, WG – TERBINAFINE, terbinafine 250 mg tablet, 42
13307J	APO-Zopiclone, TX – ZOPICLONE, zopiclone 7.5 mg tablet, 14
13307J	Imoclone, RW – ZOPICLONE, zopiclone 7.5 mg tablet, 14

Addition – Equivalence Indicator

13307J

Imovane, SW – ZOPICLONE, zopiclone 7.5 mg tablet, 14

Deletions

Deletion – Item

4468E

CROMOGLYCATE, sodium cromoglycate 2% nasal spray, 26 mL (Rynacrom)

Advance Notices

1 September 2025

Deletion – Brand

14200J	Blooms the Chemist Tamsulosin SR, IB – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30
4070F	Blooms the Chemist Tamsulosin SR, IB – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30

Efficient Funding of Chemotherapy (Private Hospital)

Additions

Addition – Item

14889P	DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi)
14932X	DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi)

Deletions

Deletion – Brand

10699D	Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules
7241D	Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules
12219D	Bortezomib Sandoz, SZ – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial
7234R	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial
7239B	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial
7234R	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial
7239B	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial

Deletion – Note

11906P

NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Note - Erratum

The administrative note ‘Special Pricing Arrangements apply.’ for durvalumab item codes 11911X, 13745K, 13766M and 13779F was inadvertently removed, the Special Pricing Arrangement note is intended to apply in August as shown in the erratum.

Alterations

Alteration – Restriction

2638W	IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)
10775D	NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11906P	NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
14664T	NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag)
10475H	PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda)
12122B	PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda)

Advance Notices

1 September 2025

Deletion – Brand

7255W	Pemetrexed APOTEX, TX – PEMETREXED, pemetrexed 500 mg injection, 1 vial
7263G	Navelbine, FB – VINORELBINE, vinorelbine 50 mg/5 mL injection, 5 mL vial

Efficient Funding of Chemotherapy (Public Hospital)

Additions

Addition – Item

14925M	DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi)
14942K	DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi)

Deletions

Deletion – Brand

10691Q	Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules
4371C	Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules
12227M	Bortezomib Sandoz, SZ – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial
4394G	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial
4431F	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial
4394G	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial
4431F	Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial

Deletion – Note

11900H

NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Note - Erratum

The administrative note ‘Special Pricing Arrangements apply.’ for durvalumab item codes 11915D, 13767N, 13775B and 13780G was inadvertently removed, the Special Pricing Arrangement note is intended to apply in August as shown in the erratum.

Alterations

Alteration – Restriction

2641B	IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)
10764M	NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11900H	NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
14678M	NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag)
10493G	PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda)
12128H	PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda)

Advance Notices

1 September 2025

Deletion – Brand

4600D	Pemetrexed APOTEX, TX – PEMETREXED, pemetrexed 500 mg injection, 1 vial
4620E	Navelbine, FB – VINORELBINE, vinorelbine 50 mg/5 mL injection, 5 mL vial

Related Pharmaceutical Benefits for Public Hospital use

Deletions

Deletion – Brand

5899L

Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule

Deletion – Equivalence Indicator

5899L

Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule

Alterations

Alteration – Item Description

From
14803D	EPCORITAMAB, epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
To
14803D	EPCORITAMAB, Epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
From
14826H	EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
To
14826H	EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
From
14827J	EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)
To
14827J	EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)

Advance Notices

1 September 2025

Deletion – Brand

5967C	APO-Ondansetron, TX – ONDANSETRON, ondansetron 4 mg tablet, 4
5968D	APO-Ondansetron, TX – ONDANSETRON, ondansetron 8 mg tablet, 4

1 October 2025

Deletion – Brand

5857G

Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 4